Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France mydrg.de

scatter_plot

Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France

• B.S.
• Mittwoch, 25.03.2009

Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France (ScienceDirect).

Kostenvergleich - MRSA - Verweildauer - URL

« The readmission rate as an indicator of the quality of elective surgical inpatient care for the elderly in New Zealand | Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France | Klinikum Emden: Chefarzt fristlos entlassen »